Skip to content

Find our latest news, stories and press releases

Delivering long-term value for our stakeholders

Explore career opportunities and more

Impacting health for humanity

  1. Home/
  2. News/
  3. Caring & giving/
  4. Bridge to Employment: 25 years of helping young people excel in school—and life
A photo of a group from Bridge to Employment

Bridge to Employment: 25 years of helping young people excel in school—and life

This Johnson & Johnson program pairs high school kids with local companies and institutes of higher learning to help set them up for success in the work world. We take a look at the inspiring statistics behind that success.

Since 1992, Johnson & Johnson’s Bridge to Employment (BTE) program has provided high schoolers with meaningful educational experiences and career prep to help set them up for success as they head off to college.

In the last 25 years, BTE has come a long way: What started as a U.S.-based program has expanded well beyond its domestic roots to encompass over 80 sites in more than 20 countries, including India, Israel, Mexico, South Africa and Spain.

Earlier this year, in fact, Johnson & Johnson India was honored with the prestigious Global CSR Leadership Award for Innovation in Corporate Social Responsibility Practices for its work mentoring 50 underprivileged students in Mumbai through the BTE program.

As the latest class of students graduates from the program on June 21, we’re taking a look at the impact BTE has had over the last quarter-century around the globe.


Johnson & Johnson’s Bridge to Employment Program

More from Johnson & Johnson

What is a rheumatic disease?

More than 200 conditions are classified as rheumatic diseases, and they tend to affect the joints and connective tissues. Here’s what a doctor wants you to know about the different types, symptoms and risk factors—and how Johnson & Johnson is innovating new treatments.

Using your own cells to fight cancer

Cell therapy is bringing the world one step closer to eliminating cancer. Here’s how Johnson & Johnson has treated more than 10,000 patients and counting with this cutting-edge therapy.

What are biologics?

Biologics, a class of medications derived from living organisms, treat a range of conditions including immune-mediated diseases and cancer. Learn how Johnson & Johnson is innovating in biologics to improve treatment options for people around the world.